On May 27, 2026, Wellgistics Health, Inc. entered into a Securities Purchase Agreement with accredited investors to sell convertible promissory notes with an aggregate principal amount of $21,132,812.50 for a cash purchase price of $16,906,250. The transaction includes PIPE warrants exercisable at $7.50 per share and notes that will automatically convert into Series A Convertible Preferred Stock on a specified Mandatory Conversion Date. The company used a portion of the proceeds to repay approximately $1.77 million in outstanding obligations to Marco Capital, Inc. Additionally, the company entered into a Placement Agency Agreement with Dawson James Securities, Inc., paying a 3% cash fee and issuing warrants with an exercise price of $6.25 per share.
